Navigation Links
Caliper Life Sciences Introduces Zephyr SPE Workstation to Improve Efficiency of Solid Phase Extraction
Date:12/11/2007

ditional information can be found online at http://www.CaliperLS.com.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of leading-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results and then translating those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit http://www.caliperLS.com.

Caliper is a registered trademark and Zephyr is a trademark of Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
2. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
3. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
4. Caliper Life Sciences Presentation at UBS Global Life Sciences Conference to be Webcast
5. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
6. Caliper Life Sciences to Participate in Deutsche Banks Healthcare Technology Industry Day
7. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
8. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... ... July 06, 2015 , ... Proove Biosciences ... bi-annual Pain Management Medical Advisory Board meeting in Palm Springs, California. At the ... Development team to discuss new clinical practice and research ideas. The Board also ...
(Date:7/6/2015)... -- Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused on women,s ... Executive Officer, and Scott Durbin , Viveve,s Chief Financial ... , , , DATE:    , , , ...     , , , 12:15 PM EDT , ...   ,    ...
(Date:7/3/2015)... 3, 2015 ... osoitteessa  http://www.openinnovationinscience.at Wienissä pidettävään ... Science" -jatkokoulutusohjelmaan 22.7.2015 asti.  ... tekemän, kansainvälisiä tutkijoita ja tiedemiehiä ... suurinta haastetta ovat kannustimien puute ...
(Date:7/3/2015)... July 3, 2015  Pomerantz LLP announces that a ... Inc. ("Puma" or the "Company")(NYSE: PBYI ) and ... United States District Court, Central District of ... behalf of a class consisting of all persons or ... and May 13, 2015 inclusive (the "Class Period").  This ...
Breaking Biology Technology:Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4
... a cell-based clinical trial that may have far-reaching implications for future ... ... 29, 2008 -- Singapore has embarked on a cell-based clinical trial ... , , , ,The trial, currently ongoing, involves up to 35 ...
... 29, Rosetta Genomics Ltd. (Nasdaq: ROSG ), a ... its,management will present at Oppenheimer 19th Annual Healthcare ... Hotel in New York,City., About MicroRNA, ... that act as master regulators and have the ...
... 29 Inverness Medical,Innovations, Inc. (Amex: IMA ), ... its financial results for the quarter,ended September 30, 2008., ... recorded net revenue of,$438.8 million compared to net revenue ... revenue increase was primarily due to $118.7 million,of incremental ...
Cached Biology Technology:Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 2Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 3Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 4Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16
(Date:6/16/2015)... YORK , June 16, 2015  With the ... world, security remains a top concern. The recent compromise ... confirms the need for strong authentication within government agencies. ... Token, a biometric one-time password (OTP) authenticator, has been ... Standards (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue ... amount to at least 340 MSEK to that it will ... in market growth and orders received the revenue guidance for ... for 2015 will exceed 1,500 MSEK to an updated guidance ... Due to receipt of orders of touch fingerprint ...
(Date:6/15/2015)... NEW YORK , June 15, 2015 ... released today from Telstra reveals the majority of US consumers ... recognise them via biometrics, such as fingerprint and voiceprint, instead ... usernames. According to Telstra,s " Mobile Identity   ... " report, with smartphones now the primary channel ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... 26,2009) Autism Speaks, the nation,s largest autism science ... $5 million to investigate genetic and environmental risk factors ... two large-scale, multi-site studies focusing on a collaborative prospective ... with autism, who are at higher genetic risk for ...
... goat born without front legs learned to walk upright. ... Johnny Eck, a "half-man" born without legs, grew naturally ... twins Abigail and Brittany Hensel live successfully with separate heads ... arm, but they manage to drive, swim, shuffle cards and ...
... research has found that modern lifestyle habits may play a ... decay. A review of the scientific evidence over ... toothpaste, good oral hygiene and health education, may override the ... published online in a Supplement to the journal Obesity ...
Cached Biology News:Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 2Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 3Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 4Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 5'Freaks' help scientist unravel nature and nurture 2'Freaks' help scientist unravel nature and nurture 3
CMRL Medium-1066 (1X) liquid...
... 11(R)-HETE is biosynthesized by the 11(R)-LOs ... and the fresh water hydra, H. ... relates to oocyte maturation and tentacle ... is also produced when aspirin-treated recombinant ...
... The PhosphatidylEthanolamine-Binding Protein (PEBP) does ... serine protease inhibitors. PEBP is ... spleen, testis, ovary, muscle, and stomach. ... involved in is exerting inhibitory activity ...
... 500 Power Supply is designed ... offers extensive programming capabilities including ... methods for you to set ... simple intuitive PowerEase interface is ...
Biology Products: